1 / 53

ACUTE RHEUMAT I C FEVER (ARF)

ACUTE RHEUMAT I C FEVER (ARF). I.U. CERRAHPA ŞA MEDICAL FACULTY DEPARTMENT OF PEDIATRICS DIVISION OF PEDIATRIC CARDIOLOGY PROF. DR. AYŞE GÜLER EROĞLU. DEFINITION.

dunn
Télécharger la présentation

ACUTE RHEUMAT I C FEVER (ARF)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ACUTE RHEUMATIC FEVER (ARF) I.U. CERRAHPAŞA MEDICAL FACULTY DEPARTMENT OF PEDIATRICS DIVISION OF PEDIATRIC CARDIOLOGY PROF. DR. AYŞE GÜLER EROĞLU

  2. DEFINITION *ARF, which consists of delayed nonsupurative sequelae of upper respiratory tract infection with group A ß-hemolytic streptococci, is a diffuse inflammatory disease of the connective tissue involving the heart, joints, brain, blood vessels, and subcutaneous tissue.

  3. INCIDENCE * Worldwide, it is the most common cause of acquired heart disease in children and young adults. * Although the incidence of ARF has declined sharply over the past six decades in the developed countries, particularly developing countries continue to experience a high incidence of this disease. * There is no difference in the incidence of ARF between males and females (chorea is more common in females).

  4. EPIDEMIOLOGY * Crowdingin inadequate housing is probably the main risk factor for acquiring streptococcal infection and resulting ARF. * The high incidence of streptococcal respiratory infections in the winter and spring probably accounts for the frequency of onset of ARF in these seasons. * ARF is more common in people with genetic predisposition. * Initial attacks of ARF are encountered most commonly in children between the ages of 5 and 15 years old.

  5. EPIDEMIOLOGY * An untreated group A streptococcal infections of the upper respiratory tract may result in ARF. * A relatively small number of M types are the most common and dangerous rheumatogenic pharyngeal strains. * The necessity for the preceding streptococcal infection to occur in the upper respiratory tract rather than skin is well documented.

  6. EPIDEMIOLOGY Upper respiratory tract infection Socioeconomic standarts School (%2) Crowding Winter 5 – 15 years old Group A ß-hemolytic streptococci ARF 1-5 (3) weeks Penicilline (-)

  7. PATHOGENESIS * ARF results from the interaction of three main factors • A causative agent (group A ß-hemolytic streptococci) • An organ site dependence (upper respiratory tract) • A vulnerable host * How the organism causes rheumatic fever is still unclear. *The most popular theory of pathogenesis is autoimmunity.

  8. PATHOGENESIS Susceptile Host Positive for HLA-DR 4,2,1,3,7 Allotype D8 /17 Grup A Streptococcus Serotypes; M3, M18 Tissue/Organ Inflammation Joints Heart Brain Vascular Connective tissue Immune Reaction Cross-Reactive Antibody and / or Cell-Mediated Immunity ACUTE RHEUMATİC FEVER

  9. Latency period between the occurrence of the streptococcal pharyngitis and the onset of the clinical manifestations of ARF.

  10. PATHOLOGY * ARF is characterized pathologically by two main lesions in the connective tissues occuring particularly around small blood vessels in heart, brain, joints and skin. * The first and the earliest lesion is exudative, degenerative, and inflammatory. This lesion contributes to transitory manifestations of ARF and responds to antiinflammatory agents. This early phase lasts 2 to 3 weeks and is followed by the second lesion.

  11. PATHOLOGY *The second characteristic lesion of ARF is a proliferative one that may persist for many months and years. Aschoff’s nodules are characteristic proliferative lesion of ARF. The proliferative lesion probably does not respond to the antiinflammatory agents. *Pericardium-serofibrinous pericarditis *Myocardium-Aschoff’s nodules, interstitial inflammation *Endocardium-mitral and aortic valvulitis and rarely tricuspid or pulmonary valvulitis *Joints-artritis heals without residual manifestations *Subcutaneous nodules-heal rapidly without sequelae

  12. J o n e s C r i t e r ia Major Manifestations • Polyarthritis • Carditis • Sydenham’s chorea • Erythema marginatum • Subcutaneous nodules Minör Manifestations Clinical • Fever • Arthralgia Laboratory • Elevated acute phase reactans Erythrocyte sedimentation C-reactive protein • Prolonged P-R interval (> 0.16") Supporting evidence of antecedent group A Streptococcal infection • Elevated ASO • Positive throat culture or • Rapid streptococcal antigen test

  13. DIAGNOSIS If supported by evidence of preceding group A streptococcal infection, the presence of two major manifestations or of one major and two minor manifestations indicates a high probability of ARF.

  14. HISTORY • * History of streptococcal pharyngitis, 1 to 5 weeks (average, 3 weeks) before the onset of symptoms, is common. The latent period may be as long as 2 to 6 months (average, 4 months) in cases of isolated chorea. • * Pallor, malaise, easy fatigability, and other history, such as epistaxis (5% to 10%) and abdominal pain, may be present. • * Family history of ARF frequently is positive.

  15. ARTHRITIS * Arthritis, the most common manifestation of ARF (70% of cases), usually involves large joints (e.g., knees, ankles, elbows, wrists). Often more than one joint, is involved, with a characteristic migratory nature of the arthritis. Swelling, heat, redness, severe pain, tenderness, and limitation of motion are common. * The arthritis responds dramatically to salicylate therapy; if patients treated with salicylates (with documented therapeutic levels) do not improve in 48 hours, the diagnosis of ARF probably is incorrect.

  16. DIFFERENTIAL DIAGNOSIS • Juvenile rheumatoidarthritis is often misdiagnosed as ARF. • The following findings suggest juvenile rheumatoid arthritis • rather than ARF: involvement of peripheral small joints, • symmetrical involvement of large joints without migratory • arthritis, pallor of the involved joints, a more indolent • course, no evidence of preceding streptococcal infection, and • the absence of prompt response to salicylate therapy within • 24 to 48 hours.

  17. DIFFERENTIAL DIAGNOSIS • * Other collagen vascular diseases (systemic lupus erythematosus, mixed connective tissue disease); reactive arthritis, including poststreptococcal arthritis; serum sickness; and infectious arthritis (such as gonococcal) occasionally require differentiation. • *Virus-associated acute arthritis (rubella, parvovirus, hepatitis B virus, herpesviruses, enteroviruses) is much more common in adults. • *Hematologic disorders, such as sicklemia and leukemia, should be considered in the differential diagnosis. • * Poststreptococcal reactive artritis

  18. CARDITIS * Frequency in ARF is 50 % (in our patients 75,4 %) *ARF may frequently involve all three layers. Pancarditis Endocarditis: Mitral regurgitation, aortic regurgitation, mitral stenosis (late sequelae) Myocarditis: Tachycardia (out of proportion to the fever that persist during sleep), congestive heart failure (CHF) Pericarditis : Friction rub, pericardial effusion, chest pain, and ECG changes

  19. MITRAL REGURGITATION (MR) * MR occurs in about 50-70% of patients with rheumatic carditis. * In our patients with ARF is seen in about 78% and occurs in about 92% of patients with rheumatic carditis • S1 is normal or diminished. • S2 may split widely. • S3 commonly present and loud. • Regurgitant systolicmurmurs at the apex, grade 2 to 4/6, transmits to left axilla • A mid-diastolic apical murmur due to edematous cusps (Carey-Coombs)

  20. MITRAL REGURGITATION ECG: Normal in mild cases Left ventricular hypertrophy (LVH) with or without left atrial enlargement (LAH) Atrial fibrillation is rare in children X-ray: LV and the LA enlarge Pulmonary vascularity usually is normal Echo: The two dimentional echo shows dilated LV and LA Color, Doppler studies can assess the severity of MR

  21. MITRAL REGURGITATION

  22. AORTIC REGURGITATION * AR occurs in about 20% of patients with rheumatic carditis. (In our patients isolated AR is seen in about 2% and associated with MR 85%) * It can be an isolated finding but is usually associated with MR.

  23. AORTIC REGURGITATION *Early diastolic decrescendo murmur that starts with the aortic component of the second heart sound, over the third left intercostal space. * In the presence of severe AR, the murmur is loud and may be associated with a diastolic thrill. * Systolic blood pressure increases (because of volume overload) and diastolic blood pressure decreases(because of aortic runoff during diastole) * In such cases, the increased pulse pressure due to the aortic runoff lesion is reflected by bounding peripheral pulses.

  24. AORTIC REGURGITATION ECG:Normal in mild cases In severe cases, LVH usually is present. LAH may be present. X-ray: Cardiomegaly involving the LV is present A dilated ascending aorta and/or a prominent aortic knob frequently are present. Pulmonary venouscongestion develops if LV failure supervenes. Echo: The LV dimention is increased, but the LA remains normal in size. Color, Doppler studies can assess the severity of AR

  25. AORTIC REGURGITATION

  26. MYOCARDITIS Myocarditis is usually accompanied by valvulitis and leads to: 1) Tachycardia (out of proportion to the fever) that persists during sleep. 2) Rapid cardiac enlargement. 3) Congestive heart failure

  27. PERICARDITIS * Pericarditis is encountered in only 5 to 10% of patients with carditis. In our patients is seen in about 10% and associated with valvulitis. * Pericarditis (friction rub, pericardial effusion, chest pain, and ECG changes) may be present. * Differential diagnosis;Isolated pericarditis is usually due to an etiology other than ARF (viral and other pericarditis, collagen vascular diseases).

  28. SYDENHAM'S CHOREA Frequency 10-15 % Girls > Boys Latency period1-6 months(4 months) It is aneuropsychiatric disorder consisting of both neurologic signs (choreic movement and hypotonia) and psychiatric signs (e.g., emotional lability, hyperactivity, seperation anxiety, obsessions and compulsions).

  29. SYDENHAM'S CHOREA * The adventitious movements, weakness, and hypotonia continue for an average of 7 months (up to 17 months) before slowly waning in severity. * Recently, elevated titers of “antineuronal antibodies” recognizing basal ganglion tissues have been found in over 90% of patients. The levels of the antineuronal antibody titer are positively related to the severity of choreic movements. * These findings suggest that chorea may be related to dysfunction of basal ganglia and cortical neuronal components. *Differential diagnosis:congenital choreoathetosis, habitual spasms, brain tumors, behavior problems

  30. Cardiac involvement of 25 patients with chorea in the Division of Pediatric Cardiology in Cerrahpaşa Medical Faculty 17 girls, 8 boys Carditis clinically (+) 7 (% 28) Carditis clinically (Ø) 18--In 14 of these patients (78%),carditis was detected with echocardiography (silent carditis) Isolated MR : 9 Isolated AR : 3 MR + AR : 2

  31. ERYTHEMA MARGINATUM * Frequency in ARF is 5-6 % (in our patients 2.6 %) * Erythema marginatum is a macular, nonpruritic rash with a serpiginous erythematous border surronding normal- looking skin. They are most commonly located on the trunk and proximal limbs and do not involve the face. * Erythema marginatum is not pathognomonic, having been reported in drug reactions and glomerulonephritis.

  32. SUBCUTANEOUS NODULES * Recent studies report a frequency of lessthan 5 % (in our patients 4,7 %) * The nodules are located on the extensor surface of the joints, particularly the elbows, knuckles, knees and ankles. Occasionally they are found on thescalp and over the spine. They vary in size from 0.5 to 2 cm and are painless and freely movable. * Subcutaneous are not pathognomic of ARF, since they occur in juvenile rheumatoid arthritis and systemic lupus erithematozus.

  33. Major manifestations in 400 patients with ARF in the Division of Pediatric Cardiology in Cerrahpaşa Medical Faculty 1965-74 1988-98 Toplam Major belirti N % N % N % % Carditis (isolated) 105 56,1 68 32 173 43,3 Arthritis (isolated) 29 15,5 44 21 73 18,5 69,1 Corea (isolated) 13 7 17 8 30 7,5 Carditis+Arthritis 22 11,8 76 36 98 24,5 Carditis+Chorea 4 2,1 2 0,9 6 1,5 29,6 Carditis+Nodules 4 2,1 1 0,5 5 1,3 Carditis+Eritema 2 1,1 2 0,5 Carditis+Arthritis+Nodules 2 1,1 3 1,4 5 1,3 Carditis+Eritema+Nodules 1 0,5 1 0,3 Carditis+Arthritis+Chorea 1 0,5 2 0,9 3 0,8 3,5 Carditis+Arthritis+Eritema 1 0,5 2 0,9 3 0,8 Carditis+Chorea+Nodules 1 0,5 1 0,3 Carditis+Arthritis+Nodules+Eritema 1 0,5 1 0,3 0,3 5 major manifestations 0 0

  34. MINOR MANIFESTATIONS • Clinical findings • * Arthralgiarefers to joint pain without the objective changes of • arthritis. It must not be considered a minor manifestation when • arthritis is present. • Fever (usually with a temperature of at least 102°F [38.8°C]) is present early in the course of untreated rheumatic fever. The classical form is very rare nowadays. • Laboratory findings • *Elevated acute-phase reactants (elevated C-reactive protein levels and elevated erythrocyte sedimentation rate) are objective evidence of an inflammatory process. • * A prolonged PR interval on the ECG is neither specific for ARFnor an indication of active carditis.

  35. Supporting evidence of antecedent group A streptococcal infection * Elevated ASO * Positive throat culture or * Rapid streptococcal antigen test

  36. Antistreptolysin O (ASO) titer is well standardized and therefore is the most widely used test.It is elevated in 80% of patients with acute rheumatic fever and in 20% of normal individuals. Only 67% of patients with isolated chorea have an elevated ASO titer. A single low ASO titer does not exclude acute rheumatic fever.

  37. Department of Pediatrics in Cerrahpaşa Medical Faculty ASO levels in ARF and other arthritisi N X <200 >200 >400 >800 >1200 % % % % % FMF(1976-78) 26 1007 15,4 84,6 61,5 41,0 34,6 Henoch-Schönlein (1977-86) 76 904 14,4 85,5 75,0 48,7 29,0 JRA (1967-79) 70 653 34,3 65,7 52,9 35,7 22,9 Non ARF arthritis 172 777 22,7 77,3 57,0 43,0 27,3 ARF (1965-74) 162 963 7,4 92,6 74,1 42,0 25,1

  38. The antideoxyribonuclease B test is favored over other tests. Titers of 240 Todd units or greater in children and 120 Todd units or greater in adults are considered elevated. • The Streptozyme test (Wampole Laboratories) is a relatively simple slide agglutination test, but it is less standardized and less reproducible than the other antibody tests. It should not be used as a definitive test for evidence of antecedent group A streptococcal infection.

  39. DIAGNOSIS A diagnosis of acute rheumatic fever is highly probable when either two major manifestations or one major and two minor manifestations, plus evidence of antecedent streptococcal infection, are present.

  40. DIAGNOSIS • * Two major manifestations are always stronger than • one major plus two minor manifestations. • * Arthralgia cannot be used as a minor manifestation in • the presence of arthritis. • * The absence of evidence of an antecedent group A • streptococcal infection is a warning that ARF is • unlikely (except when chorea is present). • The patients who show no evidence of cardiac involvement on initial examination should be monitored closely for evidence of carditis over the following 2 to 3 weeks.

  41. DIFFERENTIAL DIAGNOSIS • * The heart murmurs of ARF must be differentiated from functional murmurs, mitral valve prolapse, myocarditis, pericarditis and congenital heart diseases. • * The possibility of the early suppression of full clinical manifestations should be sought during the history taking. Subtherapeutic doses of aspirin may suppress full manifestations.

  42. CLINICAL COURSE • * In 1884 Laseque noted, ‘ARF is a disease that licks the • joints but bites the heart’ • * Only carditis can cause permanent cardiac damage (Rheumatic heart disease). Signs of mild carditis disappear rapidly in weeks, but those of severe carditis may last for 2 to 6 months. • * Arthritis subsides within a few days to several weeks, • even without treatment, and does not cause permanent • damage. • * Chorea gradually subsides in 6 to 7 months or longer and • usually does not cause permanent neurologic sequelae.

  43. PROGNOSİS Onat T, Ahunbay G: Long-term prognosis of rheumatic mitral regurgitation: Presentation of yearly prognostic regressions in relation to affecting factors. The Turkish Journal of Pediatrics 31: 185-199, 1989

  44. Onat T, Ahunbay G: Long-term prognosis of rheumatic mitral regurgitation: Presentation of yearly prognostic regressions in relation to affecting factors. The Turkish Journal of Pediatrics 31: 185-199, 1989

  45. Onat T, Ahunbay G: Long-term prognosis of acute rheumatic carditis with combined aortic and mitral regurgitation The Turkish Journal of Pediatrics 31: 185-199, 1989

  46. TREATMENT *Streptococcal eradication and prophylaxis *Treatment of clinical manifestations

  47. Streptococcal Eradication Benzathine penicillin G 600.000 Ü Im <27 kg Single dose 1.200.000 Ü Im >27 kg Single dose Penicillin-V 3x250 mg oral children 10 days 3x500 mg oral adolescents, adults 10 days Erithromycin 20-40 mg/kg/day 2-4 doses oral 10 days Prophylaxis: carditis along the life, arthritis until 21 years old or 5 years after last attack-which is longer Benzathine penicillin G 600.000 Ü Im <27 kg Every 3 weeks 1.200.000 Ü Im >27 kg Every 3 weeks Penicillin-V 2x500 mg or 2x1000 mg oral Sulfadiazine 1.0 gr oral Erithromycin 2x250 mg oral

  48. Treatment of Clinical Manifestations Antiinfinflammatory agents should be delayed until a proper clinical and laboratory diagnosis has been established.Neither salicylates nor corticosteroids guarantee termination of the disease and its cardiac damage. Carditis Oral prednisolon 2 mg/kg/day (mak.60 mg) 2-3 wk. After improvement, the therapy is with drawn gradually over 4 to 6 weeks Arthritis Alone Salicylate90-100 mg/kg/day (4 dose) 2- 3 wk. After improvement, therapy is with drawn gradually over 3 weeks The serum salicylate level should be about 25 mg/dL and should not exceed 30 mg/dL

More Related